Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael O'Doherty

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|March 29, 2011
Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010Andrea Gallamini, Michael O'Doherty
Nuclear Medicine Communications|December 20, 2007
How do we best balance optimal timing of FDG PET-CT imaging?Michael S Hofman, Michael O'Doherty
Targeted Oncology|September 22, 2009
Molecular imaging in clinical trialsDebra Josephs, James Spicer, Michael O'Doherty
Melanoma Research|August 19, 2011
The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrenceRachel Angharad Abbott, Katharine M Acland, Mark Harries, et al.
Melanoma Research|January 30, 2008
Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefitAnastasia Constantinidou, Michael Hofman, Michael O'Doherty, et al.
Nuclear Medicine Communications|December 20, 2007
Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experienceMichael S Hofman, Anastasia Constantinidou, Katharine Acland, et al.
BMJ (Clinical Research Ed.)|November 27, 2004
Completion lymphadenectomy may not increase in-transit disease in malignant melanomaRobin Russell-Jones, Ciaran Healy, Ann-Marie Powell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2013
¹⁸F-FDG PET/CT in HIV-related central nervous system pathologyScarlett Lewitschnig, Keerti Gedela, Martina Toby, et al.
Clinical Nuclear Medicine|January 22, 2014
18F-FDG PET rarely provides additional information to 11C-methionine PET imaging in hyperparathyroidismSugama Chicklore, Klaus-Martin Schulte, Nadia Talat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2008
FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's diseaseRob Barker, Fahrad Kazmi, Justin Stebbing, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|March 29, 2011
Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010Andrea Gallamini, Michael O'Doherty
Nuclear Medicine Communications|December 20, 2007
How do we best balance optimal timing of FDG PET-CT imaging?Michael S Hofman, Michael O'Doherty
Targeted Oncology|September 22, 2009
Molecular imaging in clinical trialsDebra Josephs, James Spicer, Michael O'Doherty
Melanoma Research|August 19, 2011
The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrenceRachel Angharad Abbott, Katharine M Acland, Mark Harries, et al.
Melanoma Research|January 30, 2008
Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefitAnastasia Constantinidou, Michael Hofman, Michael O'Doherty, et al.
Nuclear Medicine Communications|December 20, 2007
Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experienceMichael S Hofman, Anastasia Constantinidou, Katharine Acland, et al.
BMJ (Clinical Research Ed.)|November 27, 2004
Completion lymphadenectomy may not increase in-transit disease in malignant melanomaRobin Russell-Jones, Ciaran Healy, Ann-Marie Powell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2013
¹⁸F-FDG PET/CT in HIV-related central nervous system pathologyScarlett Lewitschnig, Keerti Gedela, Martina Toby, et al.
Clinical Nuclear Medicine|January 22, 2014
18F-FDG PET rarely provides additional information to 11C-methionine PET imaging in hyperparathyroidismSugama Chicklore, Klaus-Martin Schulte, Nadia Talat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2008
FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's diseaseRob Barker, Fahrad Kazmi, Justin Stebbing, et al.
Pageof 3